NYSE:NGVT - Ingevity Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$89.98 -0.07 (-0.08 %)
(As of 07/20/2018 04:00 PM ET)
Previous Close$90.05
Today's Range$88.89 - $90.64
52-Week Range$55.07 - $91.32
Volume296,500 shs
Average Volume232,400 shs
Market Capitalization$3.79 billion
P/E Ratio34.88
Dividend YieldN/A
Beta0.94
Ingevity logoIngevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells wood-based chemically activated carbon products primarily for gasoline vapor emission control systems. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment develops, manufactures, and sells a range of specialty chemicals derived from co-products of the Kraft pulping process. This segment's products are used in various applications comprising asphalt paving, oilfield exploration and production, printing inks, adhesives, agrochemical dispersants, lubricants, and other diverse industries. Ingevity Corporation was incorporated in 2015 and is headquartered in North Charleston, South Carolina.

Receive NGVT News and Ratings via Email

Sign-up to receive the latest news and ratings for NGVT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
SymbolNYSE:NGVT
CUSIPN/A
Phone843-740-2300

Debt

Debt-to-Equity Ratio2.34
Current Ratio2.67
Quick Ratio1.39

Price-To-Earnings

Trailing P/E Ratio34.88
Forward P/E Ratio26.01
P/E Growth2.17

Sales & Book Value

Annual Sales$972.40 million
Price / Sales3.89
Cash Flow$3.5664 per share
Price / Cash25.23
Book Value$6.60 per share
Price / Book13.63

Profitability

EPS (Most Recent Fiscal Year)$2.58
Net Income$126.50 million
Net Margins13.96%
Return on Equity48.09%
Return on Assets12.37%

Miscellaneous

Employees1,500
Outstanding Shares42,090,000
Market Cap$3,790.22

Ingevity (NYSE:NGVT) Frequently Asked Questions

What is Ingevity's stock symbol?

Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."

How were Ingevity's earnings last quarter?

Ingevity Corp (NYSE:NGVT) released its quarterly earnings data on Wednesday, May, 2nd. The company reported $0.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.63 by $0.16. The company earned $235.20 million during the quarter, compared to analysts' expectations of $231.76 million. Ingevity had a net margin of 13.96% and a return on equity of 48.09%. The firm's quarterly revenue was up 7.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.49 EPS. View Ingevity's Earnings History.

When is Ingevity's next earnings date?

Ingevity is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Ingevity.

What price target have analysts set for NGVT?

7 equities research analysts have issued 1-year price targets for Ingevity's shares. Their forecasts range from $89.00 to $102.00. On average, they expect Ingevity's share price to reach $93.75 in the next twelve months. This suggests a possible upside of 4.2% from the stock's current price. View Analyst Ratings for Ingevity.

What is the consensus analysts' recommendation for Ingevity?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Ingevity's key competitors?

Who are Ingevity's key executives?

Ingevity's management team includes the folowing people:
  • Mr. D. Michael Wilson, Pres, CEO & Director (Age 55)
  • Mr. John C. Fortson, Exec. VP, CFO & Treasurer (Age 51)
  • Ms. Katherine Pryor Burgeson, Exec. VP, Gen. Counsel & Sec. (Age 60)
  • Mr. Stuart Edward Woodcock Jr., Exec. VP & Pres of Performance Materials (Age 52)
  • Mr. Michael P. Smith, Exec. VP and Pres of Performance Chemicals, Strategy & Bus. Devel. (Age 57)

Has Ingevity been receiving favorable news coverage?

News articles about NGVT stock have trended somewhat positive this week, Accern Sentiment reports. The research firm rates the sentiment of media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Ingevity earned a news impact score of 0.11 on Accern's scale. They also gave headlines about the company an impact score of 47.12 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Who are Ingevity's major shareholders?

Ingevity's stock is owned by a number of of institutional and retail investors. Top institutional investors include Channing Capital Management LLC (1.93%), Copper Rock Capital Partners LLC (0.92%), Patten & Patten Inc. TN (0.69%), Westpac Banking Corp (0.17%), Foundry Partners LLC (0.07%) and Assenagon Asset Management S.A. (0.05%). View Institutional Ownership Trends for Ingevity.

Which institutional investors are selling Ingevity stock?

NGVT stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Channing Capital Management LLC, Copper Rock Capital Partners LLC, Patten & Patten Inc. TN, Westpac Banking Corp, Municipal Employees Retirement System of Michigan and Foundry Partners LLC. View Insider Buying and Selling for Ingevity.

Which institutional investors are buying Ingevity stock?

NGVT stock was acquired by a variety of institutional investors in the last quarter, including Mitsubishi UFJ Asset Management UK Ltd., Xact Kapitalforvaltning AB and Amalgamated Bank. View Insider Buying and Selling for Ingevity.

How do I buy shares of Ingevity?

Shares of NGVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Ingevity's stock price today?

One share of NGVT stock can currently be purchased for approximately $89.98.

How big of a company is Ingevity?

Ingevity has a market capitalization of $3.79 billion and generates $972.40 million in revenue each year. The company earns $126.50 million in net income (profit) each year or $2.58 on an earnings per share basis. Ingevity employs 1,500 workers across the globe.

How can I contact Ingevity?

Ingevity's mailing address is 5255 VIRGINIA AVENUE, NORTH CHARLESTON SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected]


MarketBeat Community Rating for Ingevity (NYSE NGVT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  162 (Vote Outperform)
Underperform Votes:  145 (Vote Underperform)
Total Votes:  307
MarketBeat's community ratings are surveys of what our community members think about Ingevity and other stocks. Vote "Outperform" if you believe NGVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NGVT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.